跳至主要内容
临床试验/CTRI/2022/10/046693
CTRI/2022/10/046693尚未招募未知

A Randomized Open-Label Interventional Clinical Study to Evaluate the Safety andEfficacy of PeaNoc XL tablets on arthritis patients with joint pain and inflammation

Apex Laboratories Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with DAS 28 (Disease Activity Score) score greater than or equal to
  • -Willingness to provide written informed consent to participate in the study.
  • -Patients understanding the nature and purpose of the study and who are
  • willing to comply with study procedures.

排除标准

  • -Patients who are taking other NSAID /Pain killers other than standard drug
  • -Abnormal results on Liver function test
  • -Patients with diabetic neuropathy
  • -Patients with severe renal, hepatic, cardiac, gastrointestinal, neurological,
  • hematological or respiratory disorder

研究者

相似试验